A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
作者信息
Hotinski Anya K, Best Oliver G, Thurgood Lauren A, Lower Karen M, Kuss Bryone J
机构信息
Genetics and Molecular Medicine, Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia.
Haematology and Genetic Pathology, Flinders Medical Centre, Bedford Park, South Australia.
出版信息
Br J Haematol. 2021 Feb;192(3):e77-e81. doi: 10.1111/bjh.17257. Epub 2020 Dec 5.
PMID:33278845
Abstract
摘要
相似文献
1
A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
Br J Haematol. 2021 Feb;192(3):e77-e81. doi: 10.1111/bjh.17257. Epub 2020 Dec 5.
2
Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):252-60. doi: 10.1016/j.clml.2012.03.005. Epub 2012 May 4.
3
Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia.
Leuk Lymphoma. 2018 Jan;59(1):59-68. doi: 10.1080/10428194.2017.1323271. Epub 2017 Jun 22.
4
Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies.
Leukemia. 2022 Jan;36(1):271-274. doi: 10.1038/s41375-021-01322-1. Epub 2021 Jun 19.
5
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
Blood. 2008 Jan 15;111(2):865-73. doi: 10.1182/blood-2007-05-092486. Epub 2007 Oct 24.
6
Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status.
Br J Haematol. 2007 Nov;139(3):507-9. doi: 10.1111/j.1365-2141.2007.06805.x. Epub 2007 Sep 14.
7
ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
Eur J Haematol. 2006 Apr;76(4):294-8. doi: 10.1111/j.1600-0609.2005.00619.x.
8
Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV and IgHV subgroups.
Leukemia. 2018 Feb;32(2):332-342. doi: 10.1038/leu.2017.177. Epub 2017 Jun 6.
9
Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia.
Br J Haematol. 2007 Jul;138(2):217-20. doi: 10.1111/j.1365-2141.2007.06636.x.
10
CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.
Br J Haematol. 2016 Jan;172(1):48-55. doi: 10.1111/bjh.13788. Epub 2015 Nov 12.
引用本文的文献
1
The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia.
Front Oncol. 2021 Dec 21;11:771669. doi: 10.3389/fonc.2021.771669. eCollection 2021.
Zotero 插件